{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:11:19Z","timestamp":1788754279402,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,30]],"date-time":"2027-06-30T00:00:00Z","timestamp":1814313600000},"content-version":"am","delay-in-days":272,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semarthrit.2026.153024","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:04:44Z","timestamp":1781967884000},"page":"153024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fibrosing myopathy in systemic sclerosis: Treatment response and clinical outcomes in a distinct subset"],"prefix":"10.1016","volume":"80","author":[{"given":"Shane","family":"Cameron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Mohassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick","family":"Wigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Hummers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8436-1601","authenticated-orcid":false,"given":"Julie J.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.semarthrit.2026.153024_bib0001","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/acr.22870","article-title":"Independent Association of severity of muscle weakness with disability as measured by the health assessment questionnaire disability index in scleroderma","volume":"68","author":"Paik","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153024_bib0002","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3899\/jrheum.151425","article-title":"Patients with systemic sclerosis\/polymyositis overlap have a worse survival rate than Patients without it","volume":"43","author":"Bhansing","year":"2016","journal-title":"J Rheumatol"},{"issue":"33","key":"10.1016\/j.semarthrit.2026.153024_bib0003","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021734","article-title":"Myopathy is a risk factor for poor prognosis of patients with systemic sclerosis: a retrospective cohort study","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.153024_bib0004","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/acr.22620","article-title":"The spectrum of muscle histopathologic findings in 42 weak scleroderma patients","volume":"67","author":"Paik","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153024_bib0005","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/acr.23291","article-title":"Association of Fibrosing myopathy in systemic sclerosis and higher mortality","volume":"69","author":"Paik","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2026.153024_bib0006","article-title":"Muscle involvement in systemic sclerosis: high mortality not associated with nature of histological lesions","author":"Le Gouellec","year":"2024","journal-title":"Rheumatology"},{"issue":"SI","key":"10.1016\/j.semarthrit.2026.153024_bib0007","doi-asserted-by":"crossref","first-page":"SI82","DOI":"10.1093\/rheumatology\/keac361","article-title":"Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort","volume":"62","author":"Matas-Garc\u00eda","year":"2023","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.153024_bib0008","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153024_bib0009","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.153024_bib0010","first-page":"46","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153024_bib0011","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153024_bib0012","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153024_bib0013","unstructured":"Follansbee W.P., Zerbe T.R., Medsger T.A. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high-risk association."},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153024_bib0014","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.153024_bib0015","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/acr.23861","article-title":"Increased morbidity and mortality of scleroderma in African Americans compared to non-African Americans","volume":"71","author":"Moore","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2026.153024_bib0016","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-021-02305-3","article-title":"Systemic sclerosis-associated myositis features minimal inflammation and characteristic capillary pathology","volume":"141","author":"Siegert","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.153024_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12840","article-title":"Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis","volume":"48","author":"Ellezam","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.153024_bib0018","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/acr.25672","article-title":"Systemic sclerosis associated myopathy in a large single-center cohort: autoantibody profiles, histologic features, and independent risk of death","volume":"78","author":"Paik","year":"2026","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.153024_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16117","article-title":"Disease spectrum of myopathies with elevated aldolase and normal creatine kinase","volume":"31","author":"Soontrapa","year":"2024","journal-title":"Eur J Neurol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:00:11Z","timestamp":1788753611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S0049017226001149"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153024","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrosing myopathy in systemic sclerosis: Treatment response and clinical outcomes in a distinct subset","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153024"}}